Back to the full story9 sources · Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 177%◆ Timeline
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 177%
12 reports in the order each was filed. Tap any entry to open that report at its source.
- 01NBC Bay AreaAug 19, 7:00 AMMerck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
- 02STATAug 19, 10:45 AMSTAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
- 03NBC NewsAug 19, 1:15 PMMerck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
- 04TimeAug 19, 1:49 PMPromising Results for mRNA Cancer Vaccine from Moderna and Merck
- 05NBC NewsAug 19, 4:45 PMMerck and Moderna say melanoma vaccine shows promise
- 06NBC NewsAug 19, 4:49 PMMerck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
- 07Ars TechnicaAug 19, 4:53 PMMRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
- 08CBS News — TopAug 19, 4:54 PMModerna stock surges as melanoma vaccine trial shows "landmark moment
- 09NBC NewsAug 19, 5:27 PMMerck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
- 10ABC7 Los AngelesAug 19, 7:11 PMPersonalized mRNA cancer vaccine shows promise in extending life span in melanoma trial
- 11The New York TimesAug 19, 7:38 PMModerna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
- 12CNBCAug 19, 8:07 PMModerna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 177%